Pomarin, Teresita B.
HRN: 25-90-33 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/02/2024
10/09/2024
IV
4.5
Q8
Septic Shock
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes